Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2003
11/26/2003EP1363937A2 Immunomodulating agents from parasitic worms and method for isolation thereof
11/26/2003EP1363934A1 Template-fixed peptidomimetics with antimicrobial activity
11/26/2003EP1363933A2 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances
11/26/2003EP1363932A2 Amphoteric sterols and the use thereof
11/26/2003EP1363929A2 Compositions and methods for the therapy and diagnosis of breast cancer
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363703A2 Disease prevention by reactivation of the thymus
11/26/2003EP1363677A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing
11/26/2003EP1363675A2 Compositions useful in gene therapy
11/26/2003EP1363674A2 Agents and methods for treating pain
11/26/2003EP1363672A1 Carrier systems comprising vitamin b12 - biodegradable micro particulate conju gates for peroral delivery of drugs, peptides/proteins and vaccines
11/26/2003EP1363670A1 Polynucleotide formulation for enhanced intracellular transfer
11/26/2003EP1363663A2 Nucleic acid mucosal immunization
11/26/2003EP1363659A2 Method of treating rhinitis or sinusitis
11/26/2003EP1363658A2 Local pain-combating agent
11/26/2003EP1363657A2 Method for promoting neovascularization using a tweak agonist and an angiogenic factor
11/26/2003EP1363656A2 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system
11/26/2003EP1363654A2 Fab i and inhibition of apicomplexan parasites
11/26/2003EP1363653A2 Methods and compositions for enhancing angiogenesis
11/26/2003EP1363643A2 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363620A2 Use of fredericamycin and its derivatives in the treatment of pin1-associated states
11/26/2003EP1363601A2 Amphoteric liposomes and the use thereof
11/26/2003EP1363550A2 A compound and method of treatment for fungal pathologies of the oral cavity
11/26/2003EP1363528A2 Methods for diagnosing and treating heart disease
11/26/2003EP1301196B1 Stimulation of bone growth with thrombin peptide derivatives
11/26/2003EP1224471B1 Dpi-6, a therapeutic biomarker in neurological disorders
11/26/2003EP1124603B1 Vaporizing device for administering sterile medication
11/26/2003EP1028977B1 Bifidus stimulating peptides and their uses
11/26/2003EP0988043B1 Method and product using sturgeon notochord for alleviating the symptoms of arthritis
11/26/2003EP0912601B1 Suppression of immune response via inhibition of cathepsin s
11/26/2003EP0888123B1 Antagonism of endothelin actions
11/26/2003EP0859627B1 Mimicking peptides in cancer therapy
11/26/2003EP0814813B1 Use of penciclovir for the treatment of human herpes-virus-8
11/26/2003EP0759693B1 METHODS FOR THE IDENTIFICATION OF COMPOUNDS CAPABLE OF ABROGATING HIV-1 Vpr-rip-1 BINDING INTERACTIONS
11/26/2003EP0705278B1 Apoptose inhibitor
11/26/2003EP0590058B1 HUMANIZED Heregulin ANTIBODy
11/26/2003CN1458977A Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
11/26/2003CN1458974A Stimulation of cartilage growth with agonists of non-protecolytically activated thrombin receptor
11/26/2003CN1458935A Integrain binding motif containing peptides and methods of treating skeletal diseases
11/26/2003CN1458846A Synthetic erythropoiesis stimulating protein
11/26/2003CN1458841A Use of matrix metalloprotease ihibitors for treatment of cancer
11/26/2003CN1458839A Dental products comprising bone growth enhancing peptide
11/26/2003CN1458170A New human protein with cancer inhibiting function and its encoding sequence
11/26/2003CN1458165A Poly peptide matter and its preparing method and use
11/26/2003CN1457902A Method for influencing sleep and relative activity to sleep
11/26/2003CN1457883A Alpha type recombined human interferon suppository and producing process
11/26/2003CN1457882A Recombined human interleukin-2 and its derivative injection and preparing method
11/26/2003CN1457881A Gelatin-blood plasma and its preparing method
11/26/2003CN1457880A Polyresistin dripping pill and its preparing method for immunodeficiency
11/26/2003CN1457879A Meningococcal vaccine and its preparing method
11/26/2003CN1128880C Blue alga transgenic expression system and method for expressing thyrnosin alpha 1
11/26/2003CN1128810C Polypeptide structure of shark liver of preventing and curing hepatitis and its purifying process
11/26/2003CN1128637C Nerve growth factor as vaccine adjuvant
11/26/2003CN1128636C Pharmaceutical angiostatic dipeptide compositions and method of use thereof
11/26/2003CN1128618C Use of histamine for elevating blood histamine
11/25/2003US6653479 Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride
11/25/2003US6653467 Antisense oligonucleotide selected from RNA or DNA, of given sequence, where each uracil is replaced with thymine; used to correct the shift of the reading frame; dystrophin
11/25/2003US6653466 Active principle comprises antisense oligonucleotide consisting of a 20 to 50-nucleotide sequence against exon 19 of dystrophin pre-mRNA
11/25/2003US6653464 Isolated nucleic acid encoding polypeptide of given sequence; use in diagnosis of infection in patients with neuropsychiatric disorders; treatment of central nervous system diseases
11/25/2003US6653460 Voltage-gated calcium channel antagonist and method
11/25/2003US6653452 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of parasitic infections, tumors, leukemias, Alzheimer's disease, autoimmune disorders and viral diseases
11/25/2003US6653450 Mutated recombinant collagens
11/25/2003US6653449 Isolated from jellyfish; use in development of drugs for treatment of sting injuries and in pharmaceuticals where platelet agglutination is desired
11/25/2003US6653448 Wnt-7B-like polypeptides and nucleic acids encoding same
11/25/2003US6653447 ULBP DNA and polypeptides
11/25/2003US6653446 Nucleotide sequences which code enzymatic polypeptide for use in treatment of gout, kidney, blood and preferential genetic disorders
11/25/2003US6653445 Chemotactic cytokine V (CCV); isolated protein of given sequence; use in diagnostics and as anti-viral or anti-tumor agent
11/25/2003US6653443 Viral infectivity factor protein (Vif) antagonist that binds to the multimerization domain within a Vif protein in a cell and inhibits Vif protein; treating acquired immunodeficiency syndrome (AIDS)
11/25/2003US6653442 Protegrins
11/25/2003US6653382 Ethylene-unsaturated carboxylic acid copolymer; ionomers; resilience, melt processability
11/25/2003US6653338 FSH mimetics for the treatment of infertility
11/25/2003US6653336 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
11/25/2003US6653303 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
11/25/2003US6653293 Administering substance stimulating infected cells to increase HIV replication; causing extracorporeal apoptosis and reinfusing blood
11/25/2003US6653287 Use of leukemia inhibitory factor and endothelin antagonists
11/25/2003US6653286 Gonadotropin releasing hormone antagonist
11/25/2003US6653285 Polypeptide inhibitors and enhancers of glycosaminoglycans such as hyaluronic acid, chondroitin sulfate, dermatan sulfate, heparin, keratan sulfate, chitin and chitosans; antiinflammatory and anticarcinogenic agents; infections
11/25/2003US6653284 Keratinocyte growth factor-2 formulations
11/25/2003US6653283 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
11/25/2003US6653282 Inhibit binding of leukocyte function- associated antigen (LFA-1) and intercellular adhesion molecule (ICAM); graft versus host disease, antiallergens, autoimmune diseases
11/25/2003US6653281 Ring modified cyclic peptide analogs
11/25/2003US6653279 Kit with container comprising insulin-like growth factor (IGF) mixed with trkB agonist to promote proliferation
11/25/2003US6653278 Selenium-containing pro-drugs for cancer therapy
11/25/2003US6653134 Obtaining a bone marrow sample from a human, isolating stromal cells, and administering to the central nervous system of the patient; treating a genetic disease, a tumor, trauma and stroke
11/25/2003US6653133 Antisense modulation of Fas mediated signaling
11/25/2003US6653125 Synthetic hepatitis C genes
11/25/2003US6653118 Deoxyribonuclease, gene encoding same and use thereof
11/25/2003US6653116 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis
11/25/2003US6653104 Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
11/25/2003US6653103 For inhibiting export of nucleic acids from nucleus to cytoplasm of a cell
11/25/2003US6653100 hKCa3/KCNN3 small conductance calcium activated potassium channel: A diagnostic marker and therapeutic target
11/25/2003US6653098 Transforming cell with an expression vector comprising an isolated polynucleotide; solubilizing the inclusion bodies; refolding and purifying; urea, dithiothreitol and cysteine; angiogenesis inhibitors; anticarcinogenic agents
11/25/2003US6653097 Human calcium channel compositions and methods
11/25/2003US6653084 Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor
11/25/2003US6653074 Methods for identifying agents which affect cellular morphology, locomotion and death
11/25/2003US6653072 Improving expression of a protein encoded by DNA substrate by assembling oligonucleotides into recombinant nucleic acids and using it to transform cells; recursive sequence recombination
11/25/2003US6652885 Complexing drug with diketopiperazine; washing; separation of impurities
11/25/2003US6652875 Casein formulations for the delivery of bioactive constituents
11/25/2003US6652873 Compositions and methods for enhancing receptor-mediated cellular internalization
1 ... 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 ... 3163